|
EXP002101
|
Transdermal siRNA delivery by pH-switchable micelles with targeting effect supp…
|
2020 |
SCP
|
siRNA
|
no |
|
yes |
yes |
yes |
|
EXP002102
|
Potent Protein Delivery into Mammalian Cells via a Supercharged Polypeptide
|
2018 |
SCP (K4)
|
not reported
|
yes |
no |
yes |
no |
no |
|
EXP002103
|
Potent Protein Delivery into Mammalian Cells via a Supercharged Polypeptide
|
2018 |
SCP (K4)
|
sgRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002104
|
Modification of Human Umbilical Cord Blood Stem Cells Using Polyethylenimine Co…
|
2017 |
mTAT
|
pDNA
|
yes |
yes |
|
no |
no |
|
EXP002105
|
Modification of Human Umbilical Cord Blood Stem Cells Using Polyethylenimine Co…
|
2017 |
mTAT
|
pDNA
|
yes |
yes |
|
no |
no |
|
EXP002106
|
Sequential delivery of VEGF siRNA and paclitaxel for PVN destruction, anti-angi…
|
2018 |
CPP (penetratin-derived)
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002107
|
Sequential delivery of VEGF siRNA and paclitaxel for PVN destruction, anti-angi…
|
2018 |
CPP (penetratin-derived)
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002108
|
NickFect type of cell-penetrating peptides present enhanced efficiency for micr…
|
2020 |
PF14
|
miRNA
|
yes |
yes |
|
no |
no |
|
EXP002109
|
NickFect type of cell-penetrating peptides present enhanced efficiency for micr…
|
2020 |
C22PF14
|
miRNA
|
yes |
yes |
|
no |
no |
|
EXP002110
|
NickFect type of cell-penetrating peptides present enhanced efficiency for micr…
|
2020 |
NF55
|
miRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002111
|
NickFect type of cell-penetrating peptides present enhanced efficiency for micr…
|
2020 |
NF70
|
miRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002112
|
NickFect type of cell-penetrating peptides present enhanced efficiency for micr…
|
2020 |
NF71
|
miRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002113
|
NickFect type of cell-penetrating peptides present enhanced efficiency for micr…
|
2020 |
NF72
|
miRNA
|
yes |
yes |
|
no |
no |
|
EXP002114
|
NickFect type of cell-penetrating peptides present enhanced efficiency for micr…
|
2020 |
MGPE9
|
miRNA
|
yes |
no |
|
no |
no |
|
EXP002115
|
NickFect type of cell-penetrating peptides present enhanced efficiency for micr…
|
2020 |
sMGPE9
|
miRNA
|
yes |
yes |
|
no |
no |
|
EXP002116
|
NickFect type of cell-penetrating peptides present enhanced efficiency for micr…
|
2020 |
NF71
|
miRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002117
|
Cell-Selective Delivery of MicroRNA with a MicroRNA–Peptide Conjugate Nanocompl…
|
2018 |
c(RGDfK)-R9
|
miRNA
|
yes |
yes |
|
no |
no |
|
EXP002118
|
Cell-Selective Delivery of MicroRNA with a MicroRNA–Peptide Conjugate Nanocompl…
|
2018 |
FA-R9
|
miRNA
|
yes |
yes |
|
no |
no |
|
EXP002119
|
Control of cancer stem cell like population by intracellular target identificat…
|
2017 |
LMWP
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002120
|
Delivery of 2-5A cargo into living cells using the Tat cell penetrating peptide…
|
2006 |
Tat(48–57)
|
oligonucleotide
|
yes |
yes |
yes |
no |
no |
|
EXP002121
|
Comparison of Nanomaterials for Delivery of Double-Stranded RNA in Caenorhabdit…
|
2020 |
poly-L-arginine (PLR)
|
siRNA
|
no |
|
no |
yes |
no |
|
EXP002122
|
Comparison of Nanomaterials for Delivery of Double-Stranded RNA in Caenorhabdit…
|
2020 |
poly-L-lysine (PLK)
|
siRNA
|
no |
|
no |
yes |
no |
|
EXP002123
|
Peptide generated anisotropic gold nanoparticles as efficient siRNA vectors
|
2019 |
LP1
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002124
|
Peptide generated anisotropic gold nanoparticles as efficient siRNA vectors
|
2019 |
LP2
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002125
|
Peptide generated anisotropic gold nanoparticles as efficient siRNA vectors
|
2019 |
LP3
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002126
|
Peptide generated anisotropic gold nanoparticles as efficient siRNA vectors
|
2019 |
LP4
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002127
|
Peptide generated anisotropic gold nanoparticles as efficient siRNA vectors
|
2019 |
LP5
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002128
|
Peptide generated anisotropic gold nanoparticles as efficient siRNA vectors
|
2019 |
LP6
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002129
|
Peptide generated anisotropic gold nanoparticles as efficient siRNA vectors
|
2019 |
LP7
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002130
|
Peptide generated anisotropic gold nanoparticles as efficient siRNA vectors
|
2019 |
LP8
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002131
|
Cell Penetrating Peptide-Based Self-Assembly for PD-L1 Targeted Tumor Regression
|
2021 |
PDL1-CPP
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002132
|
Cell Penetrating Peptide-Based Self-Assembly for PD-L1 Targeted Tumor Regression
|
2021 |
PDL1-CPP
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP002133
|
Traceable Multifunctional Micellar Nanocarriers for Cancer-Targeted Co-delivery…
|
2011 |
TAT (± RGD4C)
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002134
|
Traceable Multifunctional Micellar Nanocarriers for Cancer-Targeted Co-delivery…
|
2011 |
TAT + RGD4C
|
siRNA
|
yes |
|
yes |
yes |
no |
|
EXP002135
|
Systemic brain tumor delivery of synthetic protein nanoparticles for glioblasto…
|
2020 |
iRGD
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002136
|
Systemic brain tumor delivery of synthetic protein nanoparticles for glioblasto…
|
2020 |
iRGD
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002137
|
Cell-penetrating peptide conjugates of peptide nucleic acids as inhibitors of H…
|
2005 |
Tat
|
ASO
|
yes |
yes |
yes |
no |
no |
|
EXP002138
|
Cell-penetrating peptide conjugates of peptide nucleic acids as inhibitors of H…
|
2005 |
Transportan
|
ASO
|
yes |
yes |
yes |
no |
no |
|
EXP002139
|
Cell-penetrating peptide conjugates of peptide nucleic acids as inhibitors of H…
|
2005 |
R6-Penetratin
|
ASO
|
yes |
yes |
yes |
no |
no |
|
EXP002140
|
Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA deli…
|
2013 |
TAT
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002141
|
Systemic peptide-mediated oligonucleotide therapy improves long-term survival i…
|
2016 |
Pip6a
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP002142
|
Systemic peptide-mediated oligonucleotide therapy improves long-term survival i…
|
2016 |
Pip6a
|
ASO
|
yes |
|
|
yes |
yes |
|
EXP002143
|
Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficien…
|
2006 |
(R-Ahx-R)4
|
SCO
|
yes |
yes |
|
no |
no |
|
EXP002144
|
Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficien…
|
2006 |
Tat(48–60)
|
SCO
|
yes |
yes |
|
no |
no |
|
EXP002145
|
Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficien…
|
2006 |
R9F2
|
SCO
|
yes |
yes |
|
no |
no |
|
EXP002146
|
Cell-penetrating Peptide for Enhanced Delivery of Nucleic Acids and Drugs to Oc…
|
2008 |
POD
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002147
|
Cell-penetrating Peptide for Enhanced Delivery of Nucleic Acids and Drugs to Oc…
|
2008 |
POD
|
pDNA
|
yes |
yes |
|
no |
no |
|
EXP002148
|
Cell-penetrating Peptide for Enhanced Delivery of Nucleic Acids and Drugs to Oc…
|
2008 |
POD
|
not reported
|
yes |
|
|
yes |
no |
|
EXP002149
|
Reshaping Prostate Tumor Microenvironment To Suppress Metastasis via Cancer-Ass…
|
2019 |
Chol-R9
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002150
|
Reshaping Prostate Tumor Microenvironment To Suppress Metastasis via Cancer-Ass…
|
2019 |
Chol-R9
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002151
|
Prolongation of Life in Rats with Malignant Glioma by Intranasal siRNA/Drug Cod…
|
2014 |
Tat-modified MPEG-PCL
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002152
|
Prolongation of Life in Rats with Malignant Glioma by Intranasal siRNA/Drug Cod…
|
2014 |
Tat-modified MPEG-PCL
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002153
|
Tumor Microenvironment-Responsive Multistaged Nanoplatform for Systemic RNAi an…
|
2017 |
TCPA2
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002154
|
Tumor Microenvironment-Responsive Multistaged Nanoplatform for Systemic RNAi an…
|
2017 |
TCPA2
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002155
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
GYR
|
siRNA
|
no |
no |
|
no |
no |
|
EXP002156
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
CGY
|
siRNA
|
no |
yes |
yes |
yes |
no |
|
EXP002157
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
CGY
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002158
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
FAM-CGY
|
siRNA
|
no |
yes |
yes |
yes |
no |
|
EXP002159
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
FAM-CGY
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002160
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
CGY-(K)-FAM
|
siRNA
|
no |
yes |
yes |
yes |
no |
|
EXP002161
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
CGY-(K)-FAM
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002162
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
FAM-GYR
|
siRNA
|
no |
no |
|
no |
no |
|
EXP002163
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
FAM-CGY-SP1
|
siRNA
|
no |
yes |
yes |
yes |
no |
|
EXP002164
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
FAM-CGY-SP1
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002165
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
FAM-CGY-SP2
|
siRNA
|
no |
yes |
yes |
yes |
no |
|
EXP002166
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
FAM-CGY-SP2
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002167
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
Cy5.5-CGY
|
siRNA
|
no |
yes |
yes |
yes |
no |
|
EXP002168
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
Cy5.5-CGY
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002169
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
Cy5.5-CGY-SP1
|
siRNA
|
no |
yes |
yes |
yes |
no |
|
EXP002170
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
Cy5.5-CGY-SP1
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002171
|
Graphene oxide nanosheets in complex with cell penetrating peptides for oligonu…
|
2017 |
PF14
|
pDNA
|
yes |
yes |
|
no |
no |
|
EXP002172
|
Graphene oxide nanosheets in complex with cell penetrating peptides for oligonu…
|
2017 |
PF14
|
SCO
|
yes |
yes |
|
no |
no |
|
EXP002173
|
Graphene oxide nanosheets in complex with cell penetrating peptides for oligonu…
|
2017 |
PF14
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002174
|
Graphene oxide nanosheets in complex with cell penetrating peptides for oligonu…
|
2017 |
PF221
|
pDNA
|
yes |
yes |
|
no |
no |
|
EXP002175
|
Graphene oxide nanosheets in complex with cell penetrating peptides for oligonu…
|
2017 |
PF221
|
SCO
|
yes |
yes |
|
no |
no |
|
EXP002176
|
Graphene oxide nanosheets in complex with cell penetrating peptides for oligonu…
|
2017 |
PF221
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002177
|
Near-infrared boosted ROS responsive siRNA delivery and cancer therapy with seq…
|
2019 |
R8
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002178
|
Near-infrared boosted ROS responsive siRNA delivery and cancer therapy with seq…
|
2019 |
R8
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002179
|
Controlling fibrous capsule formation through long-term down-regulation of coll…
|
2013 |
MPGDNLS
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002180
|
Controlling fibrous capsule formation through long-term down-regulation of coll…
|
2013 |
CADY
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002181
|
Controlling fibrous capsule formation through long-term down-regulation of coll…
|
2013 |
MPGDNLS
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002182
|
Controlling fibrous capsule formation through long-term down-regulation of coll…
|
2013 |
CADY
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002183
|
Mixed Nanosized Polymeric Micelles as Promoter of Doxorubicin and miRNA-34a Co-…
|
2016 |
TATp
|
miRNA
|
yes |
yes |
|
no |
no |
|
EXP002184
|
Hyaluronic acid-modified cholesterol-conjugated cell-penetrating peptides for n…
|
2021 |
DP7-C
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002185
|
Hyaluronic acid-modified cholesterol-conjugated cell-penetrating peptides for n…
|
2021 |
DP7-C
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002186
|
Hyaluronic acid-modified cholesterol-conjugated cell-penetrating peptides for n…
|
2021 |
TAT-C
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002187
|
Hyaluronic acid-modified cholesterol-conjugated cell-penetrating peptides for n…
|
2021 |
TAT-C
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002188
|
Hyaluronic acid-modified cholesterol-conjugated cell-penetrating peptides for n…
|
2021 |
R9-C
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002189
|
Hyaluronic acid-modified cholesterol-conjugated cell-penetrating peptides for n…
|
2021 |
R9-C
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002190
|
Coated microneedles mediated intradermal delivery of octaarginine/BRAF siRNA na…
|
2018 |
R8
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002191
|
Coated microneedles mediated intradermal delivery of octaarginine/BRAF siRNA na…
|
2018 |
R8
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002192
|
Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-p…
|
2012 |
Tat-CG analog
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002193
|
Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-p…
|
2012 |
Tat-CG analog
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002194
|
Novel miR-122 delivery system based on MS2 virus like particle surface displayi…
|
2016 |
HIV-Tat (47–57)
|
miRNA
|
yes |
yes |
|
no |
no |
|
EXP002195
|
Novel miR-122 delivery system based on MS2 virus like particle surface displayi…
|
2016 |
HIV-Tat (47–57)
|
miRNA
|
yes |
|
|
yes |
yes |
|
EXP002196
|
Stealth and Fully-Laden Drug Carriers: Self-Assembled Nanogels Encapsulated wit…
|
2018 |
tumor-homing CPP (PEGA-pVEC)
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002197
|
Stealth and Fully-Laden Drug Carriers: Self-Assembled Nanogels Encapsulated wit…
|
2018 |
tumor-homing CPP (PEGA-pVEC)
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002198
|
Systemic delivery of a peptide-linked morpholino oligonucleotide neutralizes mu…
|
2013 |
Peptide B
|
ASO
|
no |
|
|
yes |
yes |
|
EXP002199
|
Systemic delivery of a peptide-linked morpholino oligonucleotide neutralizes mu…
|
2013 |
Peptide K
|
ASO
|
no |
|
|
yes |
yes |
|
EXP002200
|
Cellular delivery of a double-stranded oligonucleotide NFκB decoy by hybridizat…
|
2004 |
Transportan (TP)
|
ASO
|
yes |
yes |
|
no |
no |